Clinical trial · Observational
Hepatectomy With or Without the Thoraco-abdominal Approach
Hepatectomy With or Without the Thoraco-abdominal Approach: Impact on Perioperative Outcome
NCT03171428CI-TRIAL-00027927completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The performance of hepatectomy for liver tumors using the thoraco-abdominal approach (TAA) versus the abdominal approach (AA) is still debated. The aim of the study is the analysis of the perioperative outcome of patients operated with or without the TAA for liver tumors.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatectomy | — | UNRESOLVED | — |
| Liver Resection | — | UNRESOLVED | — |
| Liver Tumors | Liver Neoplasm | ALIAS | 0.90 |
| Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hepatectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- TAA
- description
- Thoraco-Abdominal Approach: those patients with liver tumors operated with the thoracic-abdominal approach
- interventionNames
- Procedure: Hepatectomy
- label
- AA
- description
- Abdominal Approach: those patients with liver tumors operated with the abdominal approach (without the thoracotomy)
- interventionNames
- Procedure: Hepatectomy
Primary outcomes (1)
- measure
- Short-term outcome: Occurrence of postoperative complications or death after surgery
- timeFrame
- Within 90-days after the operation
- description
- Occurrence of postoperative complications or death after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * First liver surgery; * Any type of malignant liver tumor, including hepatocellular carcinoma on cirrhosis. Exclusion Criteria: * Previous history of liver surgery; * Any type of benign liver tumor; * Incomplete clinical, surgical, pathological or postoperative data; * Patients treated with radiofrequency ablation alone or in combination with surgery were also excluded.
References
Publications (0)
Data not yet available
No reference posted for this study.